Quick Answer
Zura Bio Ltd reported R&D Expense of $42.08 million for fiscal year 2025.
Zura Bio Ltd R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $42.08M | +72.5% |
| 2024 | $24.40M | -44.5% |
| 2023 | $44.00M | +85.7% |
| 2022 | $23.69M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.95M | +98.2% | +37.3% |
| June 30, 2025 | $8.70M | +57.1% | -16.9% |
| March 31, 2025 | $10.47M | +191.5% | +73.7% |
| September 30, 2024 | $6.03M | +52.1% | +8.8% |
| June 30, 2024 | $5.54M | -80.4% | +54.2% |
| March 31, 2024 | $3.59M | -26.4% | -9.4% |
| September 30, 2023 | $3.96M | +855.4% | -86.0% |
| June 30, 2023 | $28.23M | +33111.8% | +478.0% |
- Zura Bio Ltd showed an increase of +72.5% in R&D Expense compared to the prior fiscal year.
- Over the 2022–2025 period, Zura Bio Ltd’s r&d expense has grown by 77.6% (from $23.69 million to $42.08 million).
- The most recent figure is from Zura Bio Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: